NHT
XBI icon

New Hampshire Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

New Hampshire Trust’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-129
Closed -$9.83K – 353
2023
Q1 		$9.83K Sell
129
-226
-64% -$18.8K ﹤0.01% 342
2022
Q4 		$29.5K Buy
+355
New +$28.7K 0.01% 280

Other funds holding XBI

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

New Hampshire Trust's XBI Position: Q2 2023 in Review

New Hampshire Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 129 shares — an estimated $9.83K sold.

New Hampshire Trust first reported a position in XBI in Q4 2022 and held it in 2 quarters. The position peaked at $29.5K in Q4 2022. 712 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

  • New Hampshire Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
  • New Hampshire Trust sold 129 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $9.83K.
  • New Hampshire Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 2 quarters.
  • New Hampshire Trust's State Street SPDR S&P Biotech ETF position peaked at $29.5K in Q4 2022.
  • 712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on New Hampshire Trust's 13F filing for Q2 2023, filed 11 Jul 2023.